Axin negatively affects tau phosphorylation by glycogen synthase kinase 3β

Journal of Neurochemistry

Volumn 83, Issue 4, 2002, Pages 904-913

  Stoothoff, William H ^a   Bailey, Craig D C ^a   Mi, Kaihong ^a   Lin, Sheng Cai ^b   Johnson, Gail V W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Alzheimer's disease; Axin; GSK3 ; Microtubule binding; Tau phosphorylation

Indexed keywords

AXIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MUTANT PROTEIN; PROTEASOME; TAU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

BETA CATENIN; CELL LINE; CYTOSKELETAL PROTEINS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KIDNEY; MACROMOLECULAR SUBSTANCES; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEINS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SEQUENCE DELETION; TAU PROTEINS; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0036847011     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01197.x     Document Type: Article

References (63)

1. Behrens J. (2000) Control of beta-catenin signaling in tumor development. Ann. NY Acad. Sci. 910, 21-33.
2. Behrens J., Jerchow B. A., Wurtele M., Grimm J., Asbrand C., Wirtz R., Kuhl M., Wedlich D. and Birchmeier W. (1998) Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280, 596-599.
3. Binder L. I., Frankfurter A. and Rebhun L. I. (1985) The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378.
4. Cairns N. J., Atkinson P. F., Hanger D. P., Anderton B. H., Daniel S. E. and Lantos P. L. (1997) Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci. Lett. 230, 49-52.
5. Carmel G., Mager E. M., Binder L. I. and Kuret J. (1996) The structural basis of monoclonal antibody Alz50s selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
6. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M. and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
7. Culbert A. A., Brown M. J., Frame S., Hagen T., Cross D. A., Bax B. and Reith A. D. (2001) GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett. 507, 288-294.
8. Dahmen R. P., Koch A., Denkhaus D., Tonn J. C., Sorensen N., Berthold F., Behrens J., Birchmeier W., Wiestler O. D. and Pietsch T. (2001) Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res. 61, 7039-7043.
9. Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C. and Pearl L. H. (2001) Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
10. De Ferrari G. V. and Inestrosa N. C. (2000) Wnt signaling function in Alzheimer's disease. Brain Res. Brain Res. Rev. 33, 1-12.
11. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J. and Dedhar S. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl Acad. Sci. USA 95, 11211-11216.
12. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B. and Mandelkow E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J. Cell Biol. 143, 777-794.
13. Farr G. H. III, Ferkey D. M., Yost C., Pierce S. B., Weaver C. and Kimelman D. (2000) Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J. Cell Biol. 148, 691-702.
14. Frame S., Cohen P. and Biondi R. M. (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327.
15. Fraser E., Young N., Dajani R., Franca-Koh J., Ryves J., Williams R. S., Yeo M., Webster M. T., Richardson C., Smalley M. J., Pearl L. H., Harwood A. and Dale T. C. (2002) Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J. Biol. Chem. 277, 2176-2185.
16. Godemann R., Biernat J., Mandelkow E. and Mandelkow E. M. (1999) Phosphorylation of tau protein by recombinant GSK-3beta: Pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS Lett. 454, 157-164.
17. Goedert M., Spillantini M. G., Jakes R., Rutherford D. and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
18. Goedert M., Jakes R., Crowther R. A., Cohen P., Vanmechelen E., Vandermeeren M. and Cras P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 301, 871-877.
19. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl Acad. Sci. USA 87, 5827-5831.
20. Grimes C. A. and Jope R. S. (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65, 391-426.
21. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P. and Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-3like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
22. de Hart M. J., los S. R., Albert I. N., Rubinfeld B. and Polakis P. (1998) Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 beta. Curr. Biol. 8, 573-581.
23. Hedgepeth C. M., Deardorff M. A. and Klein P. S. (1999a) Xenopus axin interacts with glycogen synthase kinase-3β and is expressed in the anterior midbrain. Mech. Dev. 80, 147-151.
24. Hedgepeth C. M., Deardorff M. A., Rankin K. and Klein P. S. (1999b) Regulation of glycogen synthase kinase 3β and downstream Wnt signaling by axin. Mol. Cell Biol. 19, 7147-7157.
25. Heisenberg C. P., Houart C., Take-Uchi M., Rauch G. J., Young N., Coutinho P., Masai I., Caneparo L., Concha M. L., Geisler R., Dale T. C., Wilson S. W. and Stemple D. L. (2001) A mutation in the Gsk3-binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon. Genes Dev. 15, 1427-1434.
26. Hinoi T., Yamamoto H., Kishida M., Takada S., Kishida S. and Kikuchi A. (2000) Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3β-dependent phosphorylation of β-catenin and down-regulates β-catenin. J. Biol. Chem 275, 34399-34406.
27. Huber A. H., Nelson W. J. and Weis W. I. (1997) Three-dimensional structure of the armadillo repeat region of β-catenin. Cell 90, 871-882.
28. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S. and Kikuchi A. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 17, 1371-1384.
29. Ishiguro K., Shiratsuchi A., Sato S., Omori A., Arioka M., Kobayashi S., Uchida T. and Imahori K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325, 167-172.
30. Itoh K., Antipova A., Ratcliffe M. J. and Sokol S. (2000) Interaction of dishevelled and Xenopus axin-related protein is required for wnt signal transduction. Mol. Cell Biol. 20, 2228-2238.
31. Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S. and Geschwind D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
32. Johnson G. V. W. and Hartigan J. A. (1999) Tau protein in normal and Alzheimer's diesease brain: An update. J. Alz. Dis. 1, 329-351.
33. Johnson G. V. W. and Jenkins S. M. (1999) Tau protein in normal and Alzheimer's disease brain. J. Alz. Dis. 1, 307-328.
34. Johnson G. V., Seubert P., Cox T. M., Motter R., Brown J. P. and Galasko D. (1997) The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433.
35. Kaytor M. D. and Orr H. T. (2002) The GSK3[β] signaling cascade and neurodegenerative disease. Curr. Opin. Neurobiol. 12, 275-278.
36. Kikuchi A. (1999) Roles of Axin in the Wnt signalling pathway. Cell Signal 11, 777-788.
37. Kishida S., Yamamoto H., Ikeda S., Kishida M., Sakamoto I., Koyama S. and Kikuchi A. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J. Biol. Chem 273, 10823-10826.
38. Lee J. S., Ishimoto A. and Yanagawa S. (1999) Characterization of mouse dishevelled (Dv1) proteins in Wnt/Wingless signaling pathway. J. Biol. Chem. 274, 21464-21470.
39. Li L., Yuan H., Weaver C. D., Mao J., Farr G. H. III, Sussman D. J., Jonkers J., Kimelman D. and Wu D. (1999) Axin and Frat1 interact with dv1 and GSK, bridging Dv1 to GSK in Wnt- mediated regulation of LEF-1. EMBO J. 18, 4233-4240.
40. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M., Hanger D., Mulot S., Marquardt B. and Stabel S., (1994). Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077-1086.
41. Lovestone S., Hartley C. L., Pearce J. and Anderton B. H. (1996) Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: The effects on the organization and stability of microtubules. Neuroscience 73, 1145-1157.
42. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R. and Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice. EMBO J. 20, 27-39.
43. Mai M., Qian C., Yokomizo A., Smith D. I. and Liu W. (1999) Cloning of the Human Homolog of Conductin (AXIN2), a Gene Mapping to Chromosome 17q23-q24. Genomics 55, 341-344.
44. Mandelkow E. M., Biernat J., Drewes G., Steiner B., Lichtenberg-Kraag B., Wille H., Gustke N. and Mandelkow E. (1993) Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann. NY Acad. Sci. 695, 209-216.
45. Mudher A., Chapman S., Richardson J., Asuni A., Gibb G., Pollard C., Killick R., Iqbal T., Raymond L., Vamdell I., Sheppard P., Makoff A., Gower E., Soden P. E., Lewis P., Murphy M., Golde T. E., Rupniak H. T., Anderton B. H. and Lovestone S. (2001) Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J. Neurosci. 21, 4987-4995.
46. Otvos L. Jr, Feiner L., Lang E., Szendrei G. I., Goedert M. and Lee V. M. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39, 669-673.
47. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B. and Cowburn R. F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer's disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019.
48. Sang H., Lu Z., Li Y., Ru B., Wang W. and Chen J. (2001) Phosphorylation of tau by glycogen synthase kinase 3β in intact mammalian cells influences the stability of microtubules. Neurosci. Lett. 312, 141-144.
49. Seidensticker M. J. and Behrens J. (2000) Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta 1495, 168-182.
50. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K. and Singh T. J. (1997) Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell Biochem. 167, 99-105.
51. Spillantini M. G., Crowther R. A. and Goedert M. (1996) Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol. 92, 42-48.
52. Spittaels K., Van Den H. C., van Dorpe J., Geerts H., Mercken M., Bruynseels K., Lasrado R., Vandezande K., Laenen I., Boon T., van Lint J., Vandenheede J., Moechars D., Loos R. and Van Leuven F. (2000) Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem. 275, 41340-41349.
53. Stamer K., Vogel R., Thies E., Mandelkow E. and Mandelkow E. M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063.
54. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R., Reese C. B., McCormick F., Tempst P., Coadwell J. and Hawkins P. T. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710-714.
55. Sutherland C., Leighton I. A. and Cohen P. (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: New kinase connections in insulin and growth-factor signalling. Biochem. J. 296, 15-19.
56. Szendrei G. I., Lee V. M. and Otvos L. Jr (1993) Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34, 243-249.
57. Thomas G. M., Frame S., Goedert M., Nathke I., Polakis P. and Cohen P. (1999) A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and β-catenin. FEBS Lett. 458, 247-251.
58. Tucholski J., Kuret J. and Johnson G. V. (1999) Tau is modified by tissue transglutaminase in situ: Possible functional and metabolic effects of polyamination. J. Neurochem. 73, 1871-1880.
59. Wagner U., Utton M., Gallo J. M. and Miller C. C. (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109, 1537-1543.
60. Welsh G. I. and Proud C. G. (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294, 625-629.
61. Yamamoto H., Kishida S., Kishida M., Ikeda S., Takada S. and Kikuchi A. (1999) Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J. Biol. Chem. 274, 10681-10684.
62. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T. J., Perry W. L. III, Lee J. J., Tilghman S. M., Gumbiner B. M. and Costantini F. (1997) The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90, 181-192.
63. Zhang Y., Neo S. Y., Wang X., Han J. and Lin S. C. (1999) Axin forms a complex with MEKK1 and activates c-Jun NH (2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J. Biol. Chem. 274, 35247-35254.